γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.

Saved in:
Bibliographic Details
Title: γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.
Authors: Ran Y; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA yran@ufl.edu tgolde@ufl.edu., Hossain F; Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Pannuti A; Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Lessard CB; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Ladd GZ; College of Pharmacy, University of Florida, Gainesville, FL, USA., Jung JI; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Minter LM; Department of Veterinary and Animal Sciences and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, MA, USA., Osborne BA; Department of Veterinary and Animal Sciences and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, MA, USA., Miele L; Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Golde TE; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA yran@ufl.edu tgolde@ufl.edu.
Source: EMBO molecular medicine [EMBO Mol Med] 2017 Jul; Vol. 9 (7), pp. 950-966.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first